Steve Lam has been appointed senior vice president of Patheon’s biologics business, reporting to Lukas Utiger, president of the company’s Drug Substance Services (DSS) segment.    Mr. Lam most recently served as vice president of operations for Amgen, where he led a company-wide initiative driving quality management processes and operational excellence. He has more than than 25 years of leadership experience in biopharmaceutical operations with a focus on manufacturing and commercializing. He...